Published in Oncol Lett on May 05, 2016
MicroRNAs in Gynecological Cancers: Small molecules with big implications. Cancer Lett (2017) 0.76
miR-381-3p suppresses the proliferation of oral squamous cell carcinoma cells by directly targeting FGFR2. Am J Cancer Res (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Most mammalian mRNAs are conserved targets of microRNAs. Genome Res (2008) 37.16
Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem (2010) 12.06
MicroRNAs in human cancer. Adv Exp Med Biol (2013) 3.19
MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics (2010) 2.80
MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation (2010) 2.03
Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. Carcinogenesis (2008) 1.87
Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer. Cancer Biol Ther (2010) 1.85
MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation. Proc Natl Acad Sci U S A (2012) 1.52
MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells. Cell Prolif (2011) 1.44
Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE. Breast Cancer Res (2000) 1.23
MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation. Clin Cancer Res (2011) 1.16
MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1. J Ovarian Res (2013) 1.15
MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition. J Ovarian Res (2013) 1.14
Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells. Drug Des Devel Ther (2014) 1.11
MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer. Prostate (2014) 1.09
Coordinated effects of microRNA-494 induce G₂/M arrest in human cholangiocarcinoma. Cell Cycle (2012) 1.08
MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer. Hepatology (2013) 1.07
Restoration of fibroblast growth factor receptor2 suppresses growth and tumorigenicity of malignant human prostate carcinoma PC-3 cells. Prostate (2004) 1.06
MiR-320 and miR-494 affect cell cycles of primary murine bronchial epithelial cells exposed to benzo[a]pyrene. Toxicol In Vitro (2009) 1.05
[MicroRNAs: novel biomarkers for human cancer]. Ann Biol Clin (Paris) (2010) 0.99
miR-186, miR-3651 and miR-494: potential biomarkers for oral squamous cell carcinoma extracted from whole blood. Oncol Rep (2014) 0.98
Regulation of Metastasis by microRNAs in Ovarian Cancer. Front Oncol (2014) 0.97
Ionizing radiation-inducible miR-494 promotes glioma cell invasion through EGFR stabilization by targeting p190B rhoGAP. Biochim Biophys Acta (2014) 0.96
miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc. J Gastroenterol Hepatol (2014) 0.95
Irradiation-induced angiogenesis is associated with an MMP-9-miR-494-syndecan-1 regulatory loop in medulloblastoma cells. Oncogene (2013) 0.95
miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells. Cell Mol Neurobiol (2015) 0.92
miR-494 represses HOXA10 expression and inhibits cell proliferation in oral cancer. Oral Oncol (2014) 0.91
MiR-26a promotes ovarian cancer proliferation and tumorigenesis. PLoS One (2014) 0.88
Fibroblast growth factor receptor 2: expression, roles, and potential as a novel molecular target for colorectal cancer. Patholog Res Int (2012) 0.88
Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth. Am J Pathol (2010) 0.88
miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway. Oncol Rep (2015) 0.87
Biomarker discovery in ovarian cancer. Womens Health (Lond Engl) (2008) 0.85
Upregulation of miR-494 Inhibits Cell Growth and Invasion and Induces Cell Apoptosis by Targeting Cleft Lip and Palate Transmembrane 1-Like in Esophageal Squamous Cell Carcinoma. Dig Dis Sci (2014) 0.82
MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc. Med Sci Monit (2016) 0.82
Environmental (nongenetic) factors in gynecological cancers: update and future perspectives. Future Oncol (2015) 0.77